AI-based liquid biopsy technology promises early detection of cancer recurrence

[News]

An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial Sloan Kettering Cancer Center (MSK).

More... (https://www.news-medical.net/news/20240614/AI-based-liquid-biopsy-technology-promises-early-detection-of-cancer-recurrence.aspx)